Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

Gideon Bollag(Universidad Estatal de Bolívar), Peter Hirth(Plexxikon (United States)), James Tsai(Plexxikon (United States)), Jiazhong Zhang(Plexxikon (United States)), Prabha N. Ibrahim(Plexxikon (United States)), Hanna Cho(Plexxikon (United States)), Wayne Spevak(Plexxikon (United States)), Chao Zhang(Plexxikon (United States)), Ying Zhang(Plexxikon (United States)), Gaston Habets(Plexxikon (United States)), Elizabeth A. Burton(Plexxikon (United States)), Bernice H. Wong(Plexxikon (United States)), Garson Tsang(Plexxikon (United States)), Brian L. West(Plexxikon (United States)), Ben Powell(Plexxikon (United States)), Rafe Shellooe(Plexxikon (United States)), Adhirai Marimuthu(Plexxikon (United States)), Hoa Nguyen(Plexxikon (United States)), Kam Y. J. Zhang(Plexxikon (United States)), Dean R. Artis(Plexxikon (United States)), Joseph Schlessinger(Yale University), Fei Su(Kingsley House), Brian Higgins(Kingsley House), Raman Iyer(Kingsley House), Kurt D’Andrea(University of Pennsylvania), Astrid Koehler(Kingsley House), Michael Stumm(Kingsley House), Paul Lin(Plexxikon (United States)), Richard J. Lee(Kingsley House), Joseph F. Grippo(Kingsley House), Igor Puzanov(Vanderbilt University), Kevin B. Kim(The University of Texas MD Anderson Cancer Center), Antoni Ribas(University of California, Los Angeles), Grant A. McArthur(Peter MacCallum Cancer Centre), Jeffrey A. Sosman(Vanderbilt University), Paul B. Chapman(Memorial Sloan Kettering Cancer Center), Keith T. Flaherty(University of Pennsylvania), Xiaowei Xu(University of Pennsylvania), Katherine L. Nathanson(University of Pennsylvania), K. B. Nolop(Plexxikon (United States))
Nature
September 1, 2010
Cited by 1,821

Abstract


Related Papers

No related papers found

Powered by citation graph analysis